Mental Wellness Program
Bio-Duloxétine duloxetine
Evaluated tools to help you understand your treatment, track what changes and know who to talk to.
Where are you in your treatment?
-
Weeks 1–2
Getting started
-
Weeks 2–6
Feeling the first effects
-
6 weeks and more
Staying on track
-
Any time
Something feels off
Essentials to get started
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
Tools by topic
Understand your treatment
How duloxetine works, and what to expect.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Antidepressants, part 2: when and how to stop
When stopping may be considered, how to taper gradually with a professional, and which withdrawal symptoms to watch for.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Podcast
One in Five, with Florence K — Episode 6: Depressive disorders
An artist's first-hand account of depression, her daughter's perspective, and a psychologist's advice for people affected and their loved ones.
-
Video
The black dog of depression
Short WHO animation that portrays depression as a "black dog" and shows that it can be tamed.
Take care of yourself day to day
Therapy, stress management and support, at your own pace.
-
Website
Relief — self-management workshops
10- to 12-week group workshops, online or in person in several Quebec regions, to live better with anxiety, depression or bipolar disorder.
-
Website
Bounce Back
Guided self-help program: phone coaching, practical workbooks and short videos to manage low mood, stress and anxiety.
-
Video
Building connections and being well surrounded
Why social connections protect mental health, with practical ideas to build and keep them.
-
App
Prezens
Short breathing, meditation and mindfulness exercises to pause and find calm.
-
App
MindDay
Daily online coaching based on recognized strategies and mindfulness, to better understand thoughts and emotions.
-
Website
Équilia — CBT and mindfulness program
Free, self-paced 6-lesson online program combining cognitive behavioural therapy and mindfulness. No waiting list.
Track what changes
Note how you feel to see how things evolve, and bring it to your appointments.
-
App
Daylio
Mood journal: log how you feel and what you did, then spot patterns. Handy to bring to your appointments.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Know when to call
What is expected, what should make you call, and who to contact.
-
Article
Understanding antidepressant medications, part 1: how to use them safely
What antidepressants do, how long they take to work, and which side effects are common at the start.
-
Article
Drugs for treatment of depression
Consumer reference on antidepressant classes, how they act, and their side effects.
-
Website
MesOutils.ca
Free Quebec platform: journal, exercises, questionnaires and a safety plan to get through difficult times.
Bio-Duloxétine products
Other duloxetine DINs on the market 48
48 products from other manufacturers. If your DIN is in this list, the tools on this page apply to you too.
| DIN | Brand | Manufacturer | Strength | Form | DPD status |
|---|---|---|---|---|---|
| 02522861 | ACCEL-DULOXETINE | ACCEL PHARMA INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02522888 | ACCEL-DULOXETINE | ACCEL PHARMA INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02572443 | APL-DULOXETINE | AJANTA PHARMA LIMITED | 30 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02572524 | APL-DULOXETINE | AJANTA PHARMA LIMITED | 60 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02432331 | DULOXETINE | ALEMBIC PHARMACEUTICALS LIMITED | 30 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02432447 | DULOXETINE | ALEMBIC PHARMACEUTICALS LIMITED | 60 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02481952 | ALTA-DULOXETINE | ALTAMED PHARMA | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02481960 | ALTA-DULOXETINE | ALTAMED PHARMA | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02475308 | AG-DULOXETINE | ANGITA PHARMA INC. | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02475316 | AG-DULOXETINE | ANGITA PHARMA INC. | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02440423 | APO-DULOXETINE | APOTEX INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02440431 | APO-DULOXETINE | APOTEX INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02436647 | AURO-DULOXETINE | AURO PHARMA INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02436655 | AURO-DULOXETINE | AURO PHARMA INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02451913 | JAMP-DULOXETINE | JAMP PHARMA CORPORATION | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02496496 | JAMP DULOXETINE | JAMP PHARMA CORPORATION | 30 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02512505 | JAMP DULOXETINE CAPSULES | JAMP PHARMA CORPORATION | 30 mg | CAPSULE (DELAYED-RELEASE) | Dormant (not currently sold) |
| 02451921 | JAMP-DULOXETINE | JAMP PHARMA CORPORATION | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02496518 | JAMP DULOXETINE | JAMP PHARMA CORPORATION | 60 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02512513 | JAMP DULOXETINE CAPSULES | JAMP PHARMA CORPORATION | 60 mg | CAPSULE (DELAYED-RELEASE) | Dormant (not currently sold) |
| 02495082 | DULOXETINE | LABORATOIRE RIVA INC. | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02495090 | DULOXETINE | LABORATOIRE RIVA INC. | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02473208 | M-DULOXETINE | MANTRA PHARMA INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02473216 | M-DULOXETINE | MANTRA PHARMA INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02438089 | IPG-DULOXETINE | MARCAN PHARMACEUTICALS INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02446081 | MAR-DULOXETINE | MARCAN PHARMACEUTICALS INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02438097 | IPG-DULOXETINE | MARCAN PHARMACEUTICALS INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02446103 | MAR-DULOXETINE | MARCAN PHARMACEUTICALS INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02438984 | MINT-DULOXETINE | MINT PHARMACEUTICALS INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02438992 | MINT-DULOXETINE | MINT PHARMACEUTICALS INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02561263 | NB-DULOXETINE | NB PHARMA INC. | 30 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02561271 | NB-DULOXETINE | NB PHARMA INC. | 60 mg | CAPSULE (DELAYED-RELEASE) | Approved, not yet marketed |
| 02482126 | NRA-DULOXETINE | NORA PHARMA INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02482134 | NRA-DULOXETINE | NORA PHARMA INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02429446 | PMS-DULOXETINE | PHARMASCIENCE INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02429454 | PMS-DULOXETINE | PHARMASCIENCE INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02452650 | PRO-DULOXETINE | PRO DOC LIMITEE | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02452669 | PRO-DULOXETINE | PRO DOC LIMITEE | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02439948 | SANDOZ DULOXETINE | SANDOZ CANADA INCORPORATED | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02439956 | SANDOZ DULOXETINE | SANDOZ CANADA INCORPORATED | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02490889 | DULOXETINE | SANIS HEALTH INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02490897 | DULOXETINE | SANIS HEALTH INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02453630 | DULOXETINE | SIVEM PHARMACEUTICALS ULC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02453649 | DULOXETINE | SIVEM PHARMACEUTICALS ULC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02457199 | TARO-DULOXETINE | TARO PHARMACEUTICALS INC | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02457202 | TARO-DULOXETINE | TARO PHARMACEUTICALS INC | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02456753 | TEVA-DULOXETINE | TEVA CANADA LIMITED | 30 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
| 02456761 | TEVA-DULOXETINE | TEVA CANADA LIMITED | 60 mg | CAPSULE (DELAYED-RELEASE) | Marketed |
For pharmacists and healthcare professionals
Every tool was evaluated against public criteria. You can share this page directly with your patients: no DIN is required.